Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Granules India gains on receiving USFDA approval for generic Methylergonovine tablets

17-May2018

Granules India gains on receiving USFDA approval for generic Methylergonovine tablets

Granules India is currently trading at Rs. 98.20, up by 1.45 points or 1.50% from its previous closing of Rs. 96.75 on the BSE.

The scrip opened at Rs. 97.90 and has touched a high and low of Rs. 98.20 and Rs. 97.65 respectively. So far 1,710 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 157.00 on 18-May-2017 and a 52 week low of Rs. 91.30 on 14-May-2018.

Last one week high and low of the scrip stood at Rs. 98.70 and Rs. 91.30 respectively. The current market cap of the company is Rs. 2,492.00 crore.

The promoters holding in the company stood at 44.94%, while Institutions and Non-Institutions held 17.55% and 37.51% respectively.

Granules India has received an approval from the United States Food & Drug Administration (USFDA) for its Abbreviated New Drug Applications (ANDA) for Methylergonovine 0.2 mg Tablets. The ANDA was filed by Granules Pharmaceuticals Inc., a wholly owned subsidiary of Granules India. The approved ANDA is the bioequivalent to the reference listed drug product (RLD), Methergine 0.2 MG.

Methylergonovine is a semi-synthetic ergot alkaloid used for the prevention and control of postpartum haemorrhage.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).



Related News

View all news

Power Grid surges on getting investment approvals

Power Grid Corporation of India is currently trading at Rs. 199.20, up by 1.05 points or 0.53 % from its previous closing of Rs. 198.15 on the BSE.The scrip opened at Rs. 198.70 and has touched a high......

Palred Technologies trades in green on the BSE

Palred Technologies is currently trading at Rs. 47.90, up by 0.95 points or 2.02% from its previous closing of Rs. 46.95 on the BSE.The scrip opened at Rs. 44.90 and has touched a high and low of Rs. 47.90......

Wipro strengthens on the bourses

Wipro is currently trading at Rs. 335.40, up by 2.65 points or 0.80% from its previous closing of Rs. 332.75 on the BSE.The scrip opened at Rs. 332.65 and has touched a high and low of Rs. 336.80 and Rs.......

Top News

View all news

Tijaria Polypipes bags order worth Rs 35.30 crore

Tijaria Polypipes has received a single order of Rs 35.30 crore for supply of HDPE & PLB Ducts from Tata Projects. The same has to be executed within a period of 3 months. The company takes great......

RIL's telecom arm enters into 5 year partnership with Star India

Reliance Industries' (RIL) telecom arm -- Reliance Jio Infocomm (Jio) -- has entered into 5 year partnership with India's leading broadcaster, Star India to unleash a new era in sports entertainment. Jio......

Sun Pharma receives Australian TGA approval for ILUMYA

Sun Pharmaceutical Industries has received the Australian Therapeutic Goods Administration (TGA) approval for its specialty product, ILUMYA (tildrakizumab) for the treatment of adults with moderate-to-severe......